Genetic control of hepatitis A severity and susceptibility to allergy

Journal of Clinical Investigation

Volumn 121, Issue 3, 2011, Pages 848-850

  Chatenoud, Lucienne ^a,b   Bach, Jean François ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGY; ATOPY; CELL FUNCTION; CLONING; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE; GENETIC REGULATION; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; NATURAL KILLER T CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; TIM1 GENE;

ANIMALS; BLOOD COAGULATION; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS A; HUMANS; HYPERSENSITIVITY; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICE; POLYMORPHISM, GENETIC; RECEPTORS, VIRUS; RISK;

EID: 79952212005     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI46418     Document Type: Note

References (20)

1. Descamps B, Jungers P, Naret C, Degott C, Zingraff J, Bach JF. HLA-A1, B8-phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients. Digestion. 1977;15(4):271-277. (Pubitemid 8120783)
2. Samson M, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382(6593):722-725.
3. Tabeta K, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol. 2006;7(2):156-164. (Pubitemid 43135881)
4. Casrouge A, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 2006;314(5797):308-312. (Pubitemid 44571977)
5. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev. 2006;214:186-201. (Pubitemid 44707911)
6. Kim HY, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest. 2011;121(3):1111-1118.
7. McIntire JJ, et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol. 2001;2(12):1109-1116. (Pubitemid 33130144)
8. Bach JF. Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopathol. 1994;72(2):156-161.
9. Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol. 2002;110(3):381-387.
10. McIntire J, et al. Immunology: hepatitis A virus link to atopic disease. Nature. 2003;425(6958):576. (Pubitemid 37280135)
11. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-920.
12. Okada H, Kuhn C, Feillet H, Bach JF. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160(1):1-9.
13. Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol. 2010;184(1):287-295.
14. Satake S, et al. Significant effect of hepatitis C virus specific CTLs on viral clearance in patients with type C chronic hepatitis treated with antiviral agents. Hepatol Res. 2008;38(5):491-500. (Pubitemid 351593950)
15. Sprengers D, et al. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans. J Hepatol. 2006;45(2):182-189.
16. Vallbracht A, et al. Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology. 1986;6(6):1308-1314. (Pubitemid 17210559)
17. McMahan RH, et al. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest. 2010; 120(12):4546-4557.
18. Sharif S, et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med. 2001;7(9):1057-1062. (Pubitemid 32937388)
19. Hong S, et al. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7(9):1052-1056. (Pubitemid 32937387)
20. Lisbonne M, et al. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol. 2003;171(4):1637-1641. (Pubitemid 36966444)